BLTE — Belite Bio Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareMid Cap
- $2.34bn
- $2.25bn
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -5.75 | -9.67 | -12.6 | -31.6 |
Depreciation | ||||
Non-Cash Items | 1.36 | 1.52 | 1.62 | 4.08 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -0.069 | 0.64 | -0.491 | -2.43 |
Change in Accounts Receivable | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Cash from Operating Activities | -4.44 | -7.47 | -11.5 | -29.8 |
Capital Expenditures | 0 | -0.074 | -0.394 | -0.063 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | -0.02 | 0.018 | 0 | 0 |
Sale of Fixed Assets | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -0.02 | -0.056 | -0.394 | -0.063 |
Financing Cash Flow Items | 0 | -0.815 | -1.03 | 54 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 28.1 | -0.583 | 37 | 76 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 23.6 | -8.27 | 24.7 | 46.1 |